Mobile

A randomized phase II trial of pemetrexed with or without PF-3512676 for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of one prior chemotherap...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-001588-52

A randomized phase II trial of pemetrexed with or without PF-3512676 for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of one prior chemotherapy regimen for advanced disease

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To assess Progression Free Survival (PFS) in patients randomized to pemetrexed plus PF-3512676 (Investigational Treatment) and in patients randomized to pemetrexed alone (Control Treatment Arm).

Critère d'inclusion

  • Treatment of patients with locally advanced or metastatic non-small lung cancer (NSLC) after failure of one prior chemotherapy regimen for advanced disease

Liens